Heme Arginate in Functional Magnetic Resonance Imaging (fMRI)

Status Active, not recruiting

Clinical Trial Summary

Ischemia reperfusion injury may be attenuated by HO-1 induction. Heme arginate showed protective effects during prolonged ischemia in animal studies. Functional blood oxygen level dependent (BOLD) magnetic resonance imaging (MRI) shall evaluate the effects of HO-1 induction during short-time ischemia in skeletal muscle of healthy subjects.

Clinical Trial Description

Ischemia reperfusion injury may be attenuated by HO-1 induction. Heme arginate showed protective effects during prolonged ischemia in animal studies. The investigators previous data confirmed strong HO-1 induction following heme arginate infusion in healthy humans. Therefore, the investigators next approach is to evaluate the direct effects of heme arginate on short time Ischemia-reperfusion (IR) injury in healthy humans. This will be done by the following surrogate markers of IR injury.

Functional blood oxygen level dependent (BOLD) magnetic resonance imaging (MRI) can measure alterations in tissue oxygenation in a high spatial and temporal resolution. This non-invasive methods therefore represent a promising technique to evaluate the effects of HO-1 induction on energy metabolism and oxygen saturation during ischemic stress and short time reperfusion in skeletal muscle.

As additional outcome, levels of myoglobin and creatine-kinase will be measured in plasma according to standard laboratory procedures. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01461512
Study type	Interventional
Source	Medical University of Vienna
Contact
Status	Active, not recruiting
Phase	Phase 2
Start date	January 2009
Completion date	December 2011

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05327348` - Effectiveness of IV Vitamin C in Reducing Oxidative Stress Associated With Free Flap Surgery	Phase 3
Completed	`NCT00184912` - The Effect of Caffeine on Ischemic Preconditioning	N/A
Recruiting	`NCT05585255` - Clinical Significance of DKK2 Protein in Cerebral Ischemia-reperfusion Injury
Completed	`NCT05598177` - Effect of Dexmedetomidine Preconditioning on Myocardial Ischemia-reperfusion Injury in Patients Undergoing Open Heart Surgery With Cardiopulmonary Bypass	Phase 4
Completed	`NCT04284592` - Remote Ischemic Postconditioning Increases HIF-1α Plasma Levels and Improves Cardiac Markers After Cardiac Surgery	N/A
Withdrawn	`NCT00441714` - Effect of Ischemic Postconditioning on Targeting of Annexin A5 After Forearm Exercise	N/A
Completed	`NCT00248040` - Reparixin in Prevention of Delayed Graft Function After Kidney Transplantation	Phase 2
Completed	`NCT01486212` - Ischemia-reperfusion Injury Model on Healthy Volunteers and Measurement of Oxidative and Inflammatory Markers	N/A
Recruiting	`NCT06097702` - A Study to Evaluate the Safety and Pharmacokinetics of BX-001N in Healthy Participants	Phase 1
Completed	`NCT01073202` - Effects of Ursodeoxycholic Acid on Graft Recovery Early After Adult Liver Transplantation	N/A
Completed	`NCT00224406` - Repertaxin in Prevention of Primary Graft Dysfunction After Lung Transplantation	Phase 2
Completed	`NCT05246618` - FIH Phase I/IIa Trial Evaluating Safety of TUM012 to Minimize Ischemic Reperfusion Injury in Kidney Transplantation	Phase 1/Phase 2
Completed	`NCT02118753` - The Effect of EPLerenone on Ischemia Reperfusion Injury in Human myoCARDium	N/A
Completed	`NCT01739088` - Pediatric Remote Ischemic Pre-conditioning Prior to Complex Cardiac Surgery	N/A
Completed	`NCT01040013` - Gut Oxygenation and Laparoscopy	Phase 2
Suspended	`NCT00184847` - Adenosine Receptors Influence Ischemia-Reperfusion Injury	N/A
Completed	`NCT01172171` - The Effect of Melatonin on Ischemia-reperfusion Injury Following Acute Myocardial Infarction	Phase 2
Completed	`NCT00457405` - Does a Seven Day Treatment With Dipyridamole Induce Protection Against Ischemia-Reperfusion Injury?	Phase 4
Completed	`NCT00184821` - Ischemic Injury and Ischemic Preconditioning in Diabetes	N/A
Not yet recruiting	`NCT00691613` - Infusion of a Single Dose of Erythropoietin to Prevent Injury in an Ischemia Reperfusion Forearm Model	N/A